Thrivent Financial for Lutherans Takes Position in Grupo Cibest S.A. – Sponsored ADR $CIB

Thrivent Financial for Lutherans bought a new position in Grupo Cibest S.A. – Sponsored ADR (NYSE:CIBFree Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 79,194 shares of the bank’s stock, valued at approximately $4,113,000.

Other institutional investors have also bought and sold shares of the company. Millennium Management LLC raised its stake in Grupo Cibest by 527.0% during the first quarter. Millennium Management LLC now owns 316,877 shares of the bank’s stock worth $12,738,000 after acquiring an additional 266,341 shares in the last quarter. Sei Investments Co. increased its position in shares of Grupo Cibest by 29.8% during the 2nd quarter. Sei Investments Co. now owns 863,718 shares of the bank’s stock worth $39,895,000 after purchasing an additional 198,228 shares in the last quarter. Candriam S.C.A. bought a new position in Grupo Cibest during the 2nd quarter valued at about $8,619,000. JPMorgan Chase & Co. boosted its position in Grupo Cibest by 22.7% in the second quarter. JPMorgan Chase & Co. now owns 939,979 shares of the bank’s stock valued at $43,418,000 after buying an additional 173,734 shares in the last quarter. Finally, Qube Research & Technologies Ltd grew its stake in Grupo Cibest by 158.7% during the second quarter. Qube Research & Technologies Ltd now owns 254,287 shares of the bank’s stock worth $11,746,000 after buying an additional 155,985 shares during the last quarter.

Grupo Cibest Stock Up 2.7%

Shares of NYSE:CIB opened at $78.34 on Friday. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.00 and a quick ratio of 1.00. The stock has a market cap of $18.84 billion, a price-to-earnings ratio of 10.76, a P/E/G ratio of 0.95 and a beta of 0.79. The company has a 50 day moving average of $70.07 and a 200-day moving average of $59.18. Grupo Cibest S.A. – Sponsored ADR has a one year low of $35.44 and a one year high of $86.31.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Santander downgraded Grupo Cibest to an “underperform” rating in a report on Wednesday, December 17th. Zacks Research lowered Grupo Cibest from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, January 20th. The Goldman Sachs Group upgraded Grupo Cibest from a “sell” rating to a “neutral” rating and raised their target price for the company from $49.00 to $69.00 in a research note on Tuesday, January 13th. Citigroup cut Grupo Cibest from a “buy” rating to a “neutral” rating in a report on Wednesday, January 21st. Finally, Weiss Ratings restated a “buy (b-)” rating on shares of Grupo Cibest in a research report on Monday, December 29th. One research analyst has rated the stock with a Buy rating, five have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus target price of $55.25.

View Our Latest Stock Report on CIB

Grupo Cibest Company Profile

(Free Report)

Bancolombia SA (NYSE: CIB) is a leading financial institution in Colombia, offering a comprehensive suite of banking and financial services. As one of the largest universal banks in the country, the company provides retail and commercial banking, corporate and investment banking, treasury services, and wealth management solutions. Through its extensive branch network and digital platforms, Bancolombia serves individual clients, small and medium enterprises, and large corporations, focusing on convenience, innovation and customer experience.

In addition to traditional banking, Bancolombia’s product portfolio includes insurance, pension fund management, leasing, factoring, brokerage and asset management.

See Also

Institutional Ownership by Quarter for Grupo Cibest (NYSE:CIB)

Receive News & Ratings for Grupo Cibest Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grupo Cibest and related companies with MarketBeat.com's FREE daily email newsletter.